A postmarket periodic safety report in the USA for approved drugs, required by FDA regulations §§314.8(c)(2) and 600.808(c)(2).
A postmarket periodic safety report in the USA for approved drugs, required by FDA regulations §§314.8(c)(2) and 600.808(c)(2).
Use our tool to look up the definition of terms in our glossary.
©2023 Trilogy Writing & Consulting GmbH | Impressum (Legal Information & Cookie Policy)